138 related articles for article (PubMed ID: 34871559)
1. Characterisation of bis(4-aminoquinoline)s as α
Chen J; Campbell AP; Wakelin LPG; Finch AM
Eur J Pharmacol; 2022 Feb; 916():174659. PubMed ID: 34871559
[TBL] [Abstract][Full Text] [Related]
2. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors.
Campbell AP; Wakelin LP; Denny WA; Finch AM
Mol Pharmacol; 2017 Feb; 91(2):135-144. PubMed ID: 27903755
[TBL] [Abstract][Full Text] [Related]
3. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM
Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075
[TBL] [Abstract][Full Text] [Related]
4. Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.
Maïga A; Merlin J; Marcon E; Rouget C; Larregola M; Gilquin B; Fruchart-Gaillard C; Lajeunesse E; Marchetti C; Lorphelin A; Bellanger L; Summers RJ; Hutchinson DS; Evans BA; Servent D; Gilles N
PLoS One; 2013; 8(7):e68841. PubMed ID: 23935897
[TBL] [Abstract][Full Text] [Related]
5. Human α1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.
Chen J; Campbell AP; Urmi KF; Wakelin LP; Denny WA; Griffith R; Finch AM
Bioorg Med Chem; 2014 Nov; 22(21):5910-6. PubMed ID: 25288493
[TBL] [Abstract][Full Text] [Related]
6. Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor.
Li Z; Li J; Liu L; Deng W; Liu Q; Liu R; Zhang W; He Z; Fan L; Yang Y; Duan Y; Hou H; Wang X; Yang Z; Wang X; Chen S; Wang Y; Huang N; Chen J
Drug Des Devel Ther; 2020; 14():2585-2594. PubMed ID: 32694911
[TBL] [Abstract][Full Text] [Related]
7. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
Docherty JR
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
[TBL] [Abstract][Full Text] [Related]
8. Both α
Alsufyani HA; McCormick PA; Docherty JR
Pharmacol Rep; 2021 Feb; 73(1):255-260. PubMed ID: 32860192
[TBL] [Abstract][Full Text] [Related]
9. α
Davis BJ; Chapple CR; Sellers DJ; Naylor AL; Sillar D; Campbell A; Chess-Williams R
J Pharmacol Sci; 2018 Aug; 137(4):366-371. PubMed ID: 30139713
[TBL] [Abstract][Full Text] [Related]
10. Diazepam is not a direct allosteric modulator of α
Williams LM; He X; Vaid TM; Abdul-Ridha A; Whitehead AR; Gooley PR; Bathgate RAD; Williams SJ; Scott DJ
Pharmacol Res Perspect; 2019 Feb; 7(1):e00455. PubMed ID: 30619611
[TBL] [Abstract][Full Text] [Related]
11. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
Smith KM; Macmillan JB; McGrath JC
Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
[TBL] [Abstract][Full Text] [Related]
12. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
Pfaffendorf M; Batink HD; Tränkle C; Mohr K; van Zwieten PA
J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of α
Docherty JR
Eur J Pharmacol; 2019 Jul; 855():305-320. PubMed ID: 31067439
[TBL] [Abstract][Full Text] [Related]
14. Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
Sato S; Hatanaka T; Yuyama H; Ukai M; Noguchi Y; Ohtake A; Taguchi K; Sasamata M; Miyata K
Biol Pharm Bull; 2012; 35(1):72-7. PubMed ID: 22223340
[TBL] [Abstract][Full Text] [Related]
15. Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter.
Kobayashi S; Tomiyama Y; Hoyano Y; Yamazaki Y; Kusama H; Itoh Y; Kubota Y; Kohri K
World J Urol; 2009 Dec; 27(6):775-80. PubMed ID: 19259685
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of zinc and copper interaction with the human alpha(1A)-adrenoceptor.
Ciolek J; Maïga A; Marcon E; Servent D; Gilles N
Eur J Pharmacol; 2011 Mar; 655(1-3):1-8. PubMed ID: 21262225
[TBL] [Abstract][Full Text] [Related]
17. Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.
Mustafa S; See HB; Seeber RM; Armstrong SP; White CW; Ventura S; Ayoub MA; Pfleger KD
J Biol Chem; 2012 Apr; 287(16):12952-65. PubMed ID: 22371491
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
[TBL] [Abstract][Full Text] [Related]
19. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
[TBL] [Abstract][Full Text] [Related]
20. Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosin.
Michel MC; Goepel M
Eur J Pharmacol; 1998 Jan; 342(1):85-92. PubMed ID: 9544796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
